SKIN autofluorescence can predict type 2 diabetes, cardiovascular disease and death according to new research published in Diabetologia, the journal of the European Association for the Study of Diabetes.
As a quick, non-invasive technique the process could be used as a suitable pharmacy screening tool, lead researcher from the University of Groningen, Netherlands, Professor Bruce Wolffenbuttel said.
Patients with type 2 diabetes have higher levels of chemicals called advanced glycation end-products which increase levels of skin "glow".
The prospective study involved 72,880 participants.
The above article was sent to subscribers in Pharmacy Daily's issue from 22 Nov 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 Nov 18
